Ondas (ONDS) stock closes higher as resale filing and Jan. 16 investor day set up next catalyst

Ondas (ONDS) stock closes higher as resale filing and Jan. 16 investor day set up next catalyst

New York, Jan 6, 2026, 21:12 (EST) — Market closed

  • ONDS ended Tuesday at $12.84. MarketWatch
  • Ondas will host a virtual OAS investor day on Jan. 16 to update its 2026 plan and financial outlook. Ondas Holdings
  • A fresh SEC filing follows a prospectus supplement that covers share resales by certain stockholders. Ondas Holdings Inc.

Ondas Holdings Inc (ONDS) shares closed up about 2.5% on Tuesday at $12.84, as investors looked ahead to a Jan. 16 investor day where the company plans to outline its 2026 outlook. The stock has also drawn attention since a prospectus supplement filed on Monday registered shares for resale by certain stockholders. SEC

The timing matters because Ondas has become a high-volatility trade in early January, and supply headlines can hit harder when a stock is moving fast. A “prospectus supplement” is an SEC document that updates a prior registration and can allow existing holders to sell shares into the market, even though it does not necessarily mean sales will happen.

A prospectus supplement dated Jan. 5 covers the resale of 2,389,203 shares by two stockholders, including Privet Ventures LLC — an investment company owned by Chief Executive Eric Brock — and Peter Higgins, the document showed. The shares were issued on Jan. 5 after holders converted notes and warrants at Ondas Autonomous Systems and exchanged the resulting stock for Ondas common shares; Ondas said it will not receive proceeds from any sales. Each holder agreed not to sell more than 5% of average daily trading volume in any single day, according to the prospectus. Ondas Holdings Inc.

Ondas said the Jan. 16 virtual investor day will focus on its Ondas Autonomous Systems unit, with updates on unmanned aerial systems and ground robots and counter-UAS, or anti-drone, products. Management said it expects to present an updated 2026 business plan, review its “Core+” growth program and discuss capital allocation, followed by a question-and-answer session. Ondas Holdings Inc.

The stock has swung sharply. Shares jumped 13.7% on Monday and rose 2.47% on Tuesday after trading between $11.96 and $12.93 in the latest session, according to price data. StockAnalysis

Ondas also pointed to momentum in autonomous systems orders late last week, saying it had received about $10 million in new purchase orders across its portfolio. Ondas Holdings Inc.

Ondas’ autonomous systems push puts it in the same defense-and-security spending lane as drone maker AeroVironment and defense contractor Kratos, among others, where contract timing and production ramp can drive sharp moves in small-cap names.

Broader markets head into Wednesday with traders watching U.S. labor-market readings — including the ADP employment report ahead of Friday’s nonfarm payrolls — for clues on interest-rate expectations and risk appetite.

But the resale registration underscores a key uncertainty: registered holders are not required to sell, yet any steady stream of stock into the market could cool momentum. Investors also risk disappointment if Ondas’ Jan. 16 outlook does not match the stock’s recent pricing.

For the next session, traders will watch whether the shares hold above $12 and can retest $13 after this week’s spike. The next scheduled company catalyst is Ondas’ OAS investor day on Jan. 16 at 10:00 a.m. ET. Ondas Holdings Inc.

Stock Market Today

  • Boston Scientific valuation flags overvaluation after multi-year rally, per DCF and valuation checks
    January 7, 2026, 8:59 PM EST. Boston Scientific (BSX) closed at $98.65, with 7-day gains of 3.5% and 30-day gains of 5.1%. The stock has rallied 173.6% over five years. The piece weighs whether the price aligns with long-term growth, noting the medical-device portfolio, launches, regulatory approvals and competition in key therapeutic areas. Our valuation checks score 1 of 6, signaling more work to resolve the value case. A Discounted Cash Flow (DCF) model pegs an intrinsic value around $68.53 per share, versus the market price, implying the stock is about 43.9% above fair value and labeled OVERVALUED. The analysis cites a latest twelve-month free cash flow of roughly $3.77 billion and outlines how two-stage projections drive the valuation.
Microchip stock leaps on upbeat sales update as traders eye Feb. 5 results
Previous Story

Microchip stock leaps on upbeat sales update as traders eye Feb. 5 results

Home Depot stock climbs 1.5% as investors brace for jobs data and rate clues
Next Story

Home Depot stock climbs 1.5% as investors brace for jobs data and rate clues

Go toTop